Bouldering and Value-Based Therapy Outperform Standard Care for Depression in New Clinical Trial

For years, clinical guidelines have recommended aerobic exercise like running or cycling as a first-line adjunct for depression. But a new clinical trial tests a fundamentally different mechanism: physical problem-solving on a bouldering wall, alongside a novel cognitive value-scheduling approach.[1]

Researchers at the University Hospital in Erlangen, Germany, published the results of a 128-person randomized controlled trial in the journal BMC Medicine on May 27, 2026. The study aimed to address the growing demand-supply gap in outpatient depression care by comparing standard treatment against two distinct group therapies.[1]

The first experimental arm, Bouldering Psychotherapy (BPT), integrates traditional psychotherapeutic interventions with the physical act of climbing. Participants climbed indoor walls up to 10 feet high without ropes or harnesses, relying on thick pads to cushion any falls.[1]

Each of the 10 weekly, two-hour BPT sessions was highly structured. The classes began with a mindfulness exercise in a separate room, transitioned to the physical climbing portion on the wall, and concluded with a relaxation component.[1]

The second experimental arm tested WISE-Therapy (WISE-T), which stands for "What's Important: Schedule and Engage." This purely cognitive approach is built on the Eisenhower Principle of time management, adapted for mental health.[1]

Rather than reacting to whatever feels most urgent in daily life, WISE-T patients are trained to identify their core personal values. They then use those values to schedule and actively engage in long-term, meaningful activities designed to combat the anhedonia that characterizes depression.[1]

After 10 weeks, both interventions significantly outperformed the control group, which received standard psychiatric care. According to the BMC Medicine data, participants in the WISE-T group saw their Montgomery-Asberg Depression Rating Scale (MADRS) scores drop by an average of 5.5 points.[1]

The bouldering group experienced a similarly robust benefit, recording a 4.2-point reduction on the MADRS scale. In contrast, the control group's scores barely changed over the same 10-week period, highlighting the efficacy of the active interventions.[1]

The trial also tracked clinical remission rates, a critical metric for long-term recovery. The WISE-T group achieved a 17.6% remission rate, which was significantly higher than the 2.6% remission rate observed in the standard care group.[1]

Beyond depression, both therapies successfully reduced anxiety scores and improved patients' overall sense of coherence. The bouldering group uniquely demonstrated a significant increase in mindfulness during physical activity, a state often described by climbers as a forced focus on the present moment.[1]

While the results are highly encouraging, the researchers noted specific limitations. The trial was conducted at a single center, and scaling Bouldering Psychotherapy requires specialized climbing gyms willing to host clinical groups, as well as therapists dually trained in mental health and climbing safety.[1][2]

"Both interventions demonstrated efficacy in reducing depressive symptoms compared with controls in this single-center setting," the research team concluded in BMC Medicine. As Outside noted in its review of the findings, "What matters most is that two very different approaches, one physical, one purely cognitive, both worked."[1]